[go: up one dir, main page]

BR9708714A - Proteína composição farmacéutica uso da proteína animais que sofrem de artrite uso dos animais e dna isolado - Google Patents

Proteína composição farmacéutica uso da proteína animais que sofrem de artrite uso dos animais e dna isolado

Info

Publication number
BR9708714A
BR9708714A BR9708714A BR9708714A BR9708714A BR 9708714 A BR9708714 A BR 9708714A BR 9708714 A BR9708714 A BR 9708714A BR 9708714 A BR9708714 A BR 9708714A BR 9708714 A BR9708714 A BR 9708714A
Authority
BR
Brazil
Prior art keywords
animals
protein
pharmaceutical composition
dna isolated
arthritis
Prior art date
Application number
BR9708714A
Other languages
English (en)
Inventor
Anna Maria Helena Boots
Gijsbertus Francisc Verheijden
Ebo Sybren Bos
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR9708714A publication Critical patent/BR9708714A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Animal Husbandry (AREA)
  • Biomedical Technology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
BR9708714A 1996-04-18 1997-04-15 Proteína composição farmacéutica uso da proteína animais que sofrem de artrite uso dos animais e dna isolado BR9708714A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/634,493 US5843449A (en) 1996-03-25 1996-04-18 Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
PCT/EP1997/001903 WO1997040149A1 (en) 1996-04-18 1997-04-15 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases

Publications (1)

Publication Number Publication Date
BR9708714A true BR9708714A (pt) 1999-08-03

Family

ID=24544023

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708714A BR9708714A (pt) 1996-04-18 1997-04-15 Proteína composição farmacéutica uso da proteína animais que sofrem de artrite uso dos animais e dna isolado

Country Status (16)

Country Link
US (1) US5843449A (pt)
EP (1) EP0904369A1 (pt)
JP (1) JP2000509265A (pt)
KR (1) KR20000005476A (pt)
CN (1) CN1216582A (pt)
AU (1) AU724547B2 (pt)
BR (1) BR9708714A (pt)
CA (1) CA2251584A1 (pt)
CZ (1) CZ333398A3 (pt)
HU (1) HU221348B1 (pt)
NO (1) NO984835L (pt)
NZ (1) NZ332311A (pt)
PL (1) PL187451B1 (pt)
RU (1) RU2189248C2 (pt)
TR (1) TR199802082T2 (pt)
WO (1) WO1997040149A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928928A (en) * 1995-06-07 1999-07-27 Universiteit Van Amsterdam Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
EP1100526A2 (en) * 1998-07-23 2001-05-23 Akzo Nobel N.V. USE OF HC gp-39 IN IMMUNE DISEASES
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
US20050197283A1 (en) * 1998-10-04 2005-09-08 Vascular Biogenics Ltd. Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
US20020102581A1 (en) * 1999-02-19 2002-08-01 Hageman Gregory S. Diagnostics and therapeutics for ocular disorders
US7534605B2 (en) 1999-06-08 2009-05-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
US7011952B2 (en) 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
AU6110301A (en) * 2000-04-29 2001-11-12 Univ Iowa Res Found Diagnostics and therapeutics for macular degeneration-related disorders
CN1352087A (zh) * 2000-11-02 2002-06-05 上海博德基因开发有限公司 一种新的多肽——人糖蛋白42和编码这种多肽的多核苷酸
GB0105360D0 (en) * 2001-03-03 2001-04-18 Glaxo Group Ltd Chimaeric immunogens
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US8195187B2 (en) 2001-06-25 2012-06-05 Airvana Network Solutions, Inc. Radio network control
US8160020B2 (en) 2001-06-25 2012-04-17 Airvana Network Solutions, Inc. Radio network control
HUP0400659A3 (en) * 2001-07-24 2005-06-28 Zhu Zhou Woodbridge Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
EP1729805A4 (en) * 2004-02-25 2008-11-26 Medimmune Inc METHODS AND COMPOSITIONS RELATED TO CHITINASES AND CHITINASE-MOLECULARS AND MODULATION OF OSTEOCLASTS
US8099504B2 (en) 2005-06-24 2012-01-17 Airvana Network Solutions, Inc. Preserving sessions in a wireless network
WO2007027748A2 (en) * 2005-08-31 2007-03-08 Medimmune, Inc. C/clp antagonists and methods of use thereof
US7751835B2 (en) 2005-10-04 2010-07-06 Airvana, Inc. Non-circular paging areas
US8094630B2 (en) 2005-12-16 2012-01-10 Airvana Network Solutions, Inc. Radio frequency dragging prevention
US8619702B2 (en) 2005-12-16 2013-12-31 Ericsson Evdo Inc. Radio network control
US8145221B2 (en) 2005-12-16 2012-03-27 Airvana Network Solutions, Inc. Radio network communication
US8085696B2 (en) 2006-07-14 2011-12-27 Airvana Networks Solutions, Inc. Dynamic modification of route update protocols
US8843638B2 (en) 2007-12-13 2014-09-23 Ericsson Evdo Inc. Handing off active connections
PE20110225A1 (es) 2008-08-05 2011-04-05 Novartis Ag Composiciones y metodos para anticuerpos que se dirigen a la proteina de complemento c5
WO2015120130A1 (en) 2014-02-07 2015-08-13 Novartis Ag Impact of genetic factors on disease progression and response to anti-c5 antibody in geographic atrophy
EP3169343B1 (en) 2014-07-15 2020-03-25 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Isolated polypeptides of cd44 and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
JPS6323898A (ja) * 1986-07-16 1988-02-01 Dainippon Pharmaceut Co Ltd 新規ポリペプチド及びそれをコ−ドするｄｎａ並びにそれらの製法
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
BR9507452A (pt) * 1994-04-08 1997-08-05 Brigham & Womens Hospital Composição farmacêutica uso de um polipeptídeo não-interferon uso de uma quantidade de um antígeno padronizado e uma quantidade de um polipeptídeo não-interferon e produto contendo (1) uma quantidade de um antígeno padronizado e (11) uma quantidade de um polipeptídeo não-interferon
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39

Also Published As

Publication number Publication date
AU724547B2 (en) 2000-09-28
US5843449A (en) 1998-12-01
TR199802082T2 (xx) 2000-09-21
PL187451B1 (pl) 2004-07-30
CZ333398A3 (cs) 1999-03-17
RU2189248C2 (ru) 2002-09-20
CN1216582A (zh) 1999-05-12
JP2000509265A (ja) 2000-07-25
EP0904369A1 (en) 1999-03-31
PL329350A1 (en) 1999-03-29
CA2251584A1 (en) 1997-10-30
HU221348B1 (en) 2002-09-28
KR20000005476A (ko) 2000-01-25
NZ332311A (en) 2000-05-26
AU2386997A (en) 1997-11-12
WO1997040149A1 (en) 1997-10-30
HUP9903378A2 (hu) 2000-02-28
HUP9903378A3 (en) 2001-01-29
NO984835L (no) 1998-12-16
NO984835D0 (no) 1998-10-16

Similar Documents

Publication Publication Date Title
BR9708714A (pt) Proteína composição farmacéutica uso da proteína animais que sofrem de artrite uso dos animais e dna isolado
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
DE69836424D1 (de) Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin
FI972657A0 (fi) Proteiinien ja peptidien aerosoliformuloinnit
FI963185A (fi) Hematopoieettinen proteiini ja materiaalit ja menetelmät sen valmistamiseksi
IS4644A (is) Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra
BR1100403A (pt) Composto e composição farmacêutica de inibidores de cox-2
DK0981375T3 (da) Farmaceutiske præparater indeholdende plasmaprotein
ATE351910T1 (de) Ob-fusionsprotein enthaltende zusammensetzungen und verfahren
BR9609831A (pt) Composições cosméticas e/ou farmacêuticas antipruríticas
BR9706311A (pt) Compostos de estilbeno composição farmacêutica composição cosmética e uso de uma composição cosmética
PT941056E (pt) Composicoes de esfingomielinase e sua utilizacao
PT907364E (pt) Composicao farmaceutica de libertacao sustida
DE59704397D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
ATE253835T1 (de) Neutralisierung von sauren nahrungs- und arzneimitteln
EP1007706A4 (en) RNA-BINDING PROTEIN AND BINDING POINT USEFUL FOR THE EXPRESSION OF RECOMBINANT MOLECULES
DE69732649D1 (de) Heteroarylsulfonamidderivate und diese enthaltende pharmazeutische zubereitungen
BR9707812A (pt) Composto composto farmacêutica e uso do composto
DE59708905D1 (de) Injektionsformulierungen von avermectinen und milbemycinen
BR9509688A (pt) Composto e composição farmacêutica
DK0925273T3 (da) Farmaceutiske præparater indeholdende 4-oxo-butansyrer
ID21034A (id) Protein kinase dan penggunaannya
MA26531A1 (fr) Composition pharmaceutique
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]